Self-explaining artificial intelligence for the classification of B cell non-Hodgkin lymphoma: A diagnostic decision support study
Michael C. Thrun(Philipps University of Marburg), Alfred Ultsch(Philipps University of Marburg), Cornelia Brendel(Philipps University of Marburg), Peter Krawitz(University of Bonn), Jörg Hoffmann(Max Planck Institute for Innovation and Competition), Andreas Neubauer(Universitätsklinikum Gießen und Marburg), Stefan W. Krause(Universitätsklinikum Erlangen), Quirin Stier(Ingenieurgesellschaft Auto und Verkehr (Germany))
Cited by 0
Related Papers
Diverse Applications of Nanomedicine
|ACS Nano|2017|1.4k
Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML)
|Leukemia|2012|417
Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial
|The Lancet Oncology|2015|402
Tolerability-Adapted Imatinib 800 mg/d Versus 400 mg/d Versus 400 mg/d Plus Interferon-α in Newly Diagnosed Chronic Myeloid Leukemia
|Journal of Clinical Oncology|2011|323